A Periaortitis Patient Who Succumbed to COVID-19 While Undergoing Systemic Steroid Therapy: A Case Report and

Ammar Abu Baker1, Qusai Aljarrah1, Mohammad Asim Eyadeh1

  • 1Department of General and Vascular Surgery, King Abdullah University Hospital (KAUH), Jordan University of Science and Technology, Irbid, Jordan.

Insights

This case report highlights the risks of systemic corticosteroids in patients with periaortitis who contract COVID-19. The study emphasizes the need for updated guidelines on managing steroid-dependent patients with inflammatory aortic conditions during the pandemic.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Rheumatology

Background:

  • Periaortitis is a rare inflammatory condition affecting the abdominal aorta, typically in middle-aged men.
  • Management strategies for periaortitis patients with COVID-19, particularly regarding steroid therapy, are not well-established.
  • Steroids have anti-inflammatory benefits but also immunosuppressive risks, creating a complex balance in COVID-19 patients.

Observation:

  • A 62-year-old man with autoimmune periaortitis was treated with high-dose corticosteroids (35 mg prednisolone/d).
  • He later developed severe COVID-19 (SARS-CoV-2 infection) with respiratory failure and sepsis.
  • The patient unfortunately died 44 days after readmission to the ICU.

Findings:

  • The case illustrates the potential dangers of maintaining high-dose steroid therapy in periaortitis patients who contract SARS-CoV-2.
  • The immunosuppressive effects of corticosteroids may exacerbate COVID-19 outcomes.

Implications:

  • There is a critical need for international consensus and updated guidelines for managing steroid-dependent patients with inflammatory aortic conditions during COVID-19.
  • Further research and comprehensive analysis of outcomes are essential for these vulnerable patients.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.